Zobrazeno 1 - 10
of 181
pro vyhledávání: '"Verheijden GF"'
Autor:
Cope, AP, Patel, SD, Hall, F, Congia, M, Hubers, HAJM, Verheijden, GF, Boots, AMH, Menon, R, Trucco, M, Rijnders, AWM, Sonderstrup, G
Publikováno v:
ARTHRITIS AND RHEUMATISM, 42(7), 1497-1507. John Wiley and Sons Inc.
Objective. To analyze the CD4+ T cell responses to the human cartilage antigen glycoprotein-39 (HCgp-39) in the context of rheumatoid arthritis (RA)-associated (DR alpha beta 1*0401) and nonassociated (DR alpha beta 1*0402) HLA class II molecules. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::a2e555a15f54af8f25085698776d3d5e
https://research.rug.nl/en/publications/87e9825d-d443-47ae-9eca-4cf511b9aa33
https://research.rug.nl/en/publications/87e9825d-d443-47ae-9eca-4cf511b9aa33
Publikováno v:
Journal of Cellular Biochemistry, 322-322. Wiley-Blackwell
STARTPAGE=322;ENDPAGE=322;ISSN=0730-2312;TITLE=Journal of Cellular Biochemistry
STARTPAGE=322;ENDPAGE=322;ISSN=0730-2312;TITLE=Journal of Cellular Biochemistry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::e81769d5fa01c0e137352b05e30e137e
https://research.rug.nl/en/publications/b3fe017a-a756-4366-ba19-f9c7a21bd220
https://research.rug.nl/en/publications/b3fe017a-a756-4366-ba19-f9c7a21bd220
Autor:
Rouwendal GJ; a Synthon Biopharmaceuticals B.V. ; Nijmegen ; The Netherlands., van der Lee MM; a Synthon Biopharmaceuticals B.V. ; Nijmegen ; The Netherlands., Meyer S; b Laboratory for Translational Immunology; University Medical Center Utrecht ; Utrecht ; The Netherlands., Reiding KR; c Center for Proteomics and Metabolomics; Leiden University Medical Center ; Leiden ; The Netherlands., Schouten J; a Synthon Biopharmaceuticals B.V. ; Nijmegen ; The Netherlands., de Roo G; a Synthon Biopharmaceuticals B.V. ; Nijmegen ; The Netherlands., Egging DF; a Synthon Biopharmaceuticals B.V. ; Nijmegen ; The Netherlands., Leusen JH; b Laboratory for Translational Immunology; University Medical Center Utrecht ; Utrecht ; The Netherlands., Boross P; b Laboratory for Translational Immunology; University Medical Center Utrecht ; Utrecht ; The Netherlands., Wuhrer M; c Center for Proteomics and Metabolomics; Leiden University Medical Center ; Leiden ; The Netherlands.; d Division of BioAnalytical Chemistry; VU University Amsterdam ; Amsterdam , The Netherlands., Verheijden GF; a Synthon Biopharmaceuticals B.V. ; Nijmegen ; The Netherlands., Dokter WH; a Synthon Biopharmaceuticals B.V. ; Nijmegen ; The Netherlands., Timmers M; a Synthon Biopharmaceuticals B.V. ; Nijmegen ; The Netherlands., Ubink R; a Synthon Biopharmaceuticals B.V. ; Nijmegen ; The Netherlands.
Publikováno v:
MAbs [MAbs] 2016; Vol. 8 (1), pp. 74-86. Date of Electronic Publication: 2015 Oct 06.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Elgersma RC, Coumans RG, Huijbregts T, Menge WM, Joosten JA, Spijker HJ, de Groot FM, van der Lee MM, Ubink R, van den Dobbelsteen DJ, Egging DF, Dokter WH, Verheijden GF, Lemmens JM, Timmers CM, Beusker PH
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2015 Jun 01; Vol. 12 (6), pp. 1813-35. Date of Electronic Publication: 2015 Feb 18.
Autor:
van der Lee MM; Department of Preclinical, Synthon Biopharmaceuticals, Nijmegen, the Netherlands., Groothuis PG; Department of Preclinical, Synthon Biopharmaceuticals, Nijmegen, the Netherlands., Ubink R; Department of Preclinical, Synthon Biopharmaceuticals, Nijmegen, the Netherlands., van der Vleuten MA; Department of Preclinical, Synthon Biopharmaceuticals, Nijmegen, the Netherlands., van Achterberg TA; Department of Preclinical, Synthon Biopharmaceuticals, Nijmegen, the Netherlands., Loosveld EM; Department of Preclinical, Synthon Biopharmaceuticals, Nijmegen, the Netherlands., Damming D; Department of Preclinical, Synthon Biopharmaceuticals, Nijmegen, the Netherlands., Jacobs DC; Department of Preclinical, Synthon Biopharmaceuticals, Nijmegen, the Netherlands., Rouwette M; Department of Preclinical, Synthon Biopharmaceuticals, Nijmegen, the Netherlands., Egging DF; Department of Preclinical, Synthon Biopharmaceuticals, Nijmegen, the Netherlands., van den Dobbelsteen D; Department of Preclinical, Synthon Biopharmaceuticals, Nijmegen, the Netherlands., Beusker PH; Department of Medicinal and Protein Chemistry, Synthon Biopharmaceuticals, Nijmegen, the Netherlands., Goedings P; Department of Medical R&D, Synthon Biopharmaceuticals, Nijmegen, the Netherlands., Verheijden GF; Department of New Molecular Entities, Synthon Biopharmaceuticals, Nijmegen, the Netherlands., Lemmens JM; Department of New Molecular Entities, Synthon Biopharmaceuticals, Nijmegen, the Netherlands., Timmers M; Department of New Molecular Entities, Synthon Biopharmaceuticals, Nijmegen, the Netherlands., Dokter WH; Department of Preclinical, Synthon Biopharmaceuticals, Nijmegen, the Netherlands. Wim.Dokter@Synthon.Com.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2015 Mar; Vol. 14 (3), pp. 692-703. Date of Electronic Publication: 2015 Jan 14.
Publikováno v:
Molecular Diversity; Aug2024, Vol. 28 Issue 4, p2617-2636, 20p
Autor:
Verbost P; Department of Pharmacology, Merck, Sharpe and Dohme MSD, 5340 BH Oss, The Netherlands., Sloot WN, Rose UM, de Leeuw R, Hanssen RG, Verheijden GF
Publikováno v:
European journal of pharmacology [Eur J Pharmacol] 2011 Jan 25; Vol. 651 (1-3), pp. 227-33. Date of Electronic Publication: 2010 Nov 27.
Autor:
Phetsanthad, Ashley1 (AUTHOR), Vu, Nhu Q.1 (AUTHOR), Yu, Qing2 (AUTHOR), Buchberger, Amanda R.1 (AUTHOR), Chen, Zhengwei1 (AUTHOR), Keller, Caitlin1 (AUTHOR), Li, Lingjun1,2 (AUTHOR) lingjun.li@wisc.edu
Publikováno v:
Mass Spectrometry Reviews. Mar2023, Vol. 42 Issue 2, p706-750. 45p.
Autor:
Boots AM; NV Organon, Research Laboratories, Oss, The Netherlands. mieke.boots@organon.com, Hubers H, Kouwijzer M, den Hoed-van Zandbrink L, Westrek-Esselink BM, van Doorn C, Stenger R, Bos ES, van Lierop MJ, Verheijden GF, Timmers CM, van Staveren CJ
Publikováno v:
Arthritis research & therapy [Arthritis Res Ther] 2007; Vol. 9 (4), pp. R71.